Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
10.16
+0.29 (2.94%)
Apr 24, 2025, 4:00 PM EDT - Market closed
CNCR Holdings List
As of Apr 23, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | SMMT | Summit Therapeutics Inc. | 2.72% |
2 | FATE | Fate Therapeutics, Inc. | 2.27% |
3 | BNTX | BioNTech SE | 1.87% |
4 | SDGR | Schrödinger, Inc. | 1.77% |
5 | ARVN | Arvinas, Inc. | 1.72% |
6 | FHTX | Foghorn Therapeutics Inc. | 1.68% |
7 | TSVT | 2seventy bio, Inc. | 1.66% |
8 | HCM | HUTCHMED (China) Limited | 1.65% |
9 | JANX | Janux Therapeutics, Inc. | 1.65% |
10 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64% |
11 | NUVB | Nuvation Bio Inc. | 1.64% |
12 | EXEL | Exelixis, Inc. | 1.64% |
13 | IMCR | Immunocore Holdings plc | 1.63% |
14 | ZYME | Zymeworks Inc. | 1.63% |
15 | IDYA | IDEAYA Biosciences, Inc. | 1.62% |
16 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.61% |
17 | ERAS | Erasca, Inc. | 1.60% |
18 | ITOS | iTeos Therapeutics, Inc. | 1.60% |
19 | IPHA | Innate Pharma S.A. | 1.60% |
20 | GMAB | Genmab A/S | 1.59% |
21 | STRO | Sutro Biopharma, Inc. | 1.59% |
22 | RVMD | Revolution Medicines, Inc. | 1.58% |
23 | NUVL | Nuvalent, Inc. | 1.55% |
24 | TYRA | Tyra Biosciences, Inc. | 1.54% |
25 | BPMC | Blueprint Medicines Corporation | 1.53% |
26 | CGEM | Cullinan Therapeutics, Inc. | 1.53% |
27 | IBRX | ImmunityBio, Inc. | 1.52% |
28 | LYEL | Lyell Immunopharma, Inc. | 1.52% |
29 | PGEN | Precigen, Inc. | 1.50% |
30 | IMTX | Immatics N.V. | 1.49% |
31 | LEGN | Legend Biotech Corporation | 1.49% |
32 | KYMR | Kymera Therapeutics, Inc. | 1.47% |
33 | RCUS | Arcus Biosciences, Inc. | 1.46% |
34 | RLAY | Relay Therapeutics, Inc. | 1.46% |
35 | MRUS | Merus N.V. | 1.46% |
36 | VOR | Vor Biopharma Inc. | 1.45% |
37 | CMPX | Compass Therapeutics, Inc. | 1.45% |
38 | ACLX | Arcellx, Inc. | 1.44% |
39 | KURA | Kura Oncology, Inc. | 1.44% |
40 | INBX | Inhibrx Biosciences, Inc. | 1.44% |
41 | ALLO | Allogene Therapeutics, Inc. | 1.43% |
42 | BCYC | Bicycle Therapeutics plc | 1.43% |
43 | REGN | Regeneron Pharmaceuticals, Inc. | 1.43% |
44 | YMAB | Y-mAbs Therapeutics, Inc. | 1.43% |
45 | DAWN | Day One Biopharmaceuticals, Inc. | 1.41% |
46 | IOVA | Iovance Biotherapeutics, Inc. | 1.40% |
47 | ELVN | Enliven Therapeutics, Inc. | 1.39% |
48 | XNCR | Xencor, Inc. | 1.38% |
49 | NRIX | Nurix Therapeutics, Inc. | 1.37% |
50 | MRK | Merck & Co., Inc. | 1.37% |
As of Apr 23, 2025